Sierra Oncology, Inc.

ORBIMED ADVISORS LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

1,964,770

Value ($000)

108,043

Weight

2.0%

2020 Q1 - 2022 Q2 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	108,043	2.0%	1,964,770	6/30/2022
2022 Q1	5/16/2022	62,971	1.0%	1,964,770	3/31/2022
2021 Q4	2/14/2022	32,117	0.4%	1,477,320	12/31/2021
2021 Q3	11/15/2021	32,383	0.4%	1,477,320	9/30/2021
2021 Q2	8/16/2021	28,763	0.3%	1,477,320	6/30/2021
2021 Q1	5/17/2021	25,454	0.2%	1,477,320	3/31/2021
2020 Q4	2/16/2021	23,681	0.2%	1,477,320	12/31/2020
2020 Q3	11/16/2020	15,763	0.2%	1,477,320	9/30/2020
2020 Q2	8/14/2020	17,876	0.3%	1,477,320	6/30/2020
2020 Q1	5/15/2020	14,507	0.2%	1,477,320	3/31/2020